相似文献
1
Psoriatic arthritis imaging: a review of scoring methods.
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii61-4. doi: 10.1136/ard.2004.030809.
2
[The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].
Ann Dermatol Venereol. 2011 May;138(5 Suppl 1):H11-5. doi: 10.1016/S0151-9638(11)70067-9.
3
Radiographic scoring methods in psoriatic arthritis.
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S55-9. Epub 2015 Oct 15.
4
Reliability of radiographic scoring methods in axial psoriatic arthritis.
Arthritis Care Res (Hoboken). 2014 Sep;66(9):1417-22. doi: 10.1002/acr.22308.
5
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
Arthritis Rheum. 2007 Aug;56(8):2698-707. doi: 10.1002/art.22805.
6
Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis.
Radiol Med. 2019 Nov;124(11):1071-1086. doi: 10.1007/s11547-019-01001-3. Epub 2019 Feb 9.
7
The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis.
J Rheumatol. 2015 Nov;42(11):2110-7. doi: 10.3899/jrheum.150165. Epub 2015 Oct 15.
8
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis.
J Rheumatol. 2009 May;36(5):1006-11. doi: 10.3899/jrheum.080491. Epub 2009 Mar 30.
9
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study.
Lancet Rheumatol. 2025 Feb;7(2):e118-e126. doi: 10.1016/S2665-9913(24)00232-7. Epub 2024 Oct 30.
10
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.
Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1.
引用本文的文献
1
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis.
Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD013614. doi: 10.1002/14651858.CD013614.pub2.
2
Imaging in clinical trials for psoriatic arthritis: a scoping review.
Skeletal Radiol. 2025 Feb 6. doi: 10.1007/s00256-025-04884-8.
3
Imaging in psoriatic arthritis: established methods and emerging techniques.
Ther Adv Musculoskelet Dis. 2024 Oct 16;16:1759720X241288060. doi: 10.1177/1759720X241288060. eCollection 2024.
4
Multimodal imaging of structural damage and inflammation in psoriatic arthritis: a comparison of DMARD-naive and DMARD-failure patients.
Rheumatology (Oxford). 2025 Apr 1;64(4):1760-1769. doi: 10.1093/rheumatology/keae450.
5
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.
Ther Adv Musculoskelet Dis. 2024 May 30;16:1759720X241240913. doi: 10.1177/1759720X241240913. eCollection 2024.
6
Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort.
RMD Open. 2024 May 24;10(2):e004080. doi: 10.1136/rmdopen-2024-004080.
7
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort.
RMD Open. 2024 Apr 5;10(2):e003841. doi: 10.1136/rmdopen-2023-003841.
8
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.
Rheumatol Ther. 2024 Jun;11(3):617-632. doi: 10.1007/s40744-024-00654-5. Epub 2024 Mar 18.
9
Targeted Therapies in Psoriatic Arthritis-An Update.
Int J Mol Sci. 2023 Mar 28;24(7):6384. doi: 10.3390/ijms24076384.
10
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies.
ACR Open Rheumatol. 2023 Apr;5(4):227-240. doi: 10.1002/acr2.11537. Epub 2023 Mar 7.
本文引用的文献
1
The long-term use of azathioprine in patients with psoriatic arthritis.
J Clin Rheumatol. 2001 Jun;7(3):160-5. doi: 10.1097/00124743-200106000-00005.
2
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
Arthritis Rheum. 2004 Jul;50(7):2264-72. doi: 10.1002/art.20335.
3
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.
Arthritis Rheum. 2004 Jul;50(7):2082-93. doi: 10.1002/art.20350.
4
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet. 2004 Feb 28;363(9410):675-81. doi: 10.1016/S0140-6736(04)15640-7.
5
Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients.
J Rheumatol. 2003 Dec;30(12):2585-9.
6
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.
Rheumatology (Oxford). 2002 Dec;41(12):1346-56. doi: 10.1093/rheumatology/41.12.1346.
7
Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.
Arthritis Rheum. 2001 Oct;44(10):2242-6. doi: 10.1002/1529-0131(200110)44:10<2242::aid-art386>3.0.co;2-f.
8
A method to score radiographic change in psoriatic arthritis.
Z Rheumatol. 2001 Jun;60(3):156-66. doi: 10.1007/s003930170064.
9
Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis.
J Rheumatol. 2001 May;28(5):1041-4.
10
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
Zotero 插件